Michael P. Kim, MD, FACS

Peer-Reviewed Articles

1. Ngo-Huang AT, Parker NH, Xiao LC, Schadler KL, Petzel MQB, Prakash LR, Kim MP, Tzeng CD, Lee JE, Ikoma N, Wolff RA, Javle MM, Koay EJ, Pant SD, Folloder JP, Wang X, Cotto AM, Ju YR, Garg N, Wang H, Bruera ED, Basen-Engquist KM, Katz MHG. Effects of a pragmatic home-based exercise program concurrent with neoadjuvant therapy on physical function of patients with pancreatic cancer: The Pancfit Randomized Clinical Trial. Ann Surg. e-Pub 2023.
2. Newhook TE, Vreeland TJ, Griffin JF, Tidwell RSS, Prakash LR, Koay EJ, Ludmir EB, Smaglo BG, Pant S, Overman M, Wolff RA, Ikoma N, Maxwell J, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognosis associated with CA19-9 response dynamics and normalization during neoadjuvant therapy in resected pancreatic adenocarcinoma. Ann Surg 277(3):484-490, 2023. e-Pub 2022. PMID: 36649067.
3. Hester CA, Kothari AN, Mason M, Maxwell J, Ikoma N, Kim MP, Tzeng CD, Lee JE, Katz MHG, Cao HST. Surgical eligibility does not imply surgical equity: Recommendations for curative treatment in patients with stage I/II pancreatic head adenocarcinoma differ by age and race. Ann Surg 277(2):321-328, 2023. e-Pub 2023. PMID: 34183508.
4. Donovan EC, Prakash LR, Chiang YJ, Bruno ML, Maxwell JE, Ikoma N, Tzeng CD, Katz MHG, Lee JE, Kim MP. Incidence of postoperative complications following pancreatectomy for pancreatic cystic lesions or pancreatic cancer. J Gastrointest Surg 27(2):319-327, 2023. e-Pub 2022. PMID: 36443557.
5. Amirkhosravi F, Kim MP. Complex Robotic Lung Resection. Thorac Surg Clin 33(1):51-60, 2023. PMID: 36372533.
6. Hirata Y, Maxwell JE, Kim MP, Tzeng CD, Katz MHG, Ikoma N. Transmesocolic Approach for Robotic Duodenal Operations. Ann Surg Oncol 30(5):2959. e-Pub 2023. PMID: 36752968.
7. Ayabe RI, Prakash LR, Bruno ML, Newhook TE, Maxwell JE, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD.. Differential gains in surgical outcomes for high-risk vs low-risk pancreatoduodenectomy with successive refinements of risk-stratified care pathways. J Am Coll Surg. e-Pub 2023. PMID: 36786469.
8. Mahadevan KK, McAndrews KM, LeBleu VS, Yang S, Lyu H, Li B, Sockwell AM, Kirtley ML, Morse SJ, Moreno Diaz BA, Kim MP, Feng N, Lopez AM, Guerrero PA, Sugimoto H, Arian KA, Ying H, Barekatain Y, Kelly PJ, Maitra A, Heffernan TP, Kalluri R. Oncogenic Kras G12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 + T cells dependent manner. bioRxiv, 2023.
9. Ikoma N, Seo YD, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Katz MHG. Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci 30(1):e1-e2, 2023. e-Pub 2022. PMID: 35950790.
10. Thaiparambil J, Dong J, Grimm SL, Perera D, Ambati CSR, Putluri V, Robertson MJ, Patel TD, Mistretta B, Gunaratne PH, Kim MP, Yustein JT, Putluri N, Coarfa C, El-Zein R. Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer. Cancer Med 12(1):584-596, 2023. e-Pub 2022. PMID: 35676822.
11. Gulhati P, Schalck A, Jiang S, Shang X, Wu CJ, Hou P, Ruiz SH, Soto LS, Parra E, Ying H, Han J, Dey P, Li J, Deng P, Sei E, Maeda DY, Zebala JA, Spring DJ, Kim MP, Wang H, Maitra A, Moore D, Clise-Dwyer K, Wang YA, Navin NE, DePinho RA. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer. Nat Cancer. e-Pub 2022. PMID: 36585453.
12. Kang Y, Deng J, Ling J, Li X, Chiang YJ, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, Tzeng CD, Lee JE, DePinho RA, Wolff RA, Pant S, McAllister F, Katz MH, Fleming JB, Kim MP. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest 132(24):e151604, 2022. e-Pub 2022.
13. Kim MP, Del Calvo H, Chihara R, Chan EY. Video-based curriculum improves resident participation during robot-assisted surgery. J Thorac Dis 14(12):4641-4649, 2022. PMID: 36647487.
14. DiPeri TP, Newhook TE, Prakash LR, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first. J Surg Oncol 126(6):1021-1027, 2022. e-Pub 2022. PMID: 35726394.
15. Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim MP, Lee JE, Katz MH, Tamm E, Bhosale P, Taniguchi CM, Holliday EB, Smith GL, Ludmir EB, Minsky BD, Crane CH, Koong AC, Das P, Wang X, Javle M, Krishnan S. Nab-Paclitaxel, capecitabine, and radiation therapy after induction chemotherapy in treating patients with locally advanced and borderline resectable pancreatic cancer: Phase 1 trial and imaging-based biomarker validation. Int J Radiat Oncol Biol Phys 1;114(3):444-453, 2022. e-Pub 2022. PMID: 35863672.
16. Schalck A, Sakellariou-Thompson D, Forget MA, Sei E, Hughes TG, Reuben A, Bai S, Hu M, Kumar T, Hurd MW, Katz MHG, Tzeng CD, Pant S, Javle M, Fogelman DR, Maitra A, Haymaker CL, Kim MP, Navin NE, Bernatchez C. Single cell sequencing reveals trajectory of tumor-infiltrating lymphocyte states in pancreatic cancer. Cancer Discov 12(10):2330-2349, 2022. PMID: 35849783.
17. Hester CA, Perri G, Prakash LR, Maxwell JE, Ikoma N, Kim MP, Tzeng CD, Smaglo B, Wolff R, Javle M, Overman MJ, Lee JE, Katz MHG. Radiographic and serologic response to first-line chemotherapy in unresected localized pancreatic cancer. J Natl Compr Canc Netw 20(8):887-897, 2022. PMID: 35948035.
18. Witt RG, Hirata Y, Prakash LR, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Lee JE, Vauthey JN, Katz MHG, Tzeng CD, Ikoma N. Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. e-Pub 2022.
19. Witt RG, Newhook TE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Association of patient controlled analgesia and total inpatient opioid use after pancreatectomy. J Surg Res 275:244-451, 2022. e-Pub 2022. PMID: 35306260.
20. Lee J, Yu A, Ali F, Ahmed O, Lynch P, Ge P, Coronel E, Kim MP, Coronel M, Folloder J, Katz M. The conundrum in endoscopic management of duodenal polyps: A tertiary cancer center experience. Expert Rev Gastroenterol Hepatol 16(2):569-576, 2022. e-Pub 2022. PMID: 35687675.
21. Newton AD, Newhook TE, Bruno ML, Prakash L, Chiang YJ, Arango NP, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Iterative changes in risk-stratified pancreatectomy clinical pathways and accelerated discharge after pancreaticoduodenectomy. J Gastrointest Surg 26(5):1054-1062, 2022. e-Pub 2022. PMID: 35023033.
22. Oppliger FA, Prakash LR, Newhook TE, Chiang YJ, Ikoma N, Maxwell JE, Kim MP, Vauthey JN, Lee JE, Katz MH, Tzeng CD. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surg Oncol 40:101673, 2022. e-Pub 2021. PMID: 34894620.
23. Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ. NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clin Transl Radiat Oncol 11(33):66-69, 2022. e-Pub 2022. PMID: 35097226.
24. Vreeland TJ, Bohan PMK, Newhook TE, Allen CJ, Prakash LR, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Contemporary assessment of need for palliative bypass after aborted pancreatoduodenectomy following neoadjuvant therapy. J Gastrointest Surg 26(2):352-359, 2022. e-Pub 2022. PMID: 35064457.
25. Ikoma N, Kim MP, Tran Cao HS, Prakash LP, Maxwell JE, Tzeng CD, Mansfield PF, Lee JE, Badgwell BD, Katz MHG. Early experience of a robotic foregut surgery program at a cancer center: Video of shared steps in robotic pancreatoduodenectomy and gastrectomy. Ann Surg Oncol 29(1):285, 2022. e-Pub 2021. PMID: 34515886.
26. Newhook TE, Prakash LR, Soliz J, Hancher-Hodges S, Speer BB, Wilks JA, Bruno ML, Dewhurst WL, Arvide EM, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy. J Surg Oncol 124(8):1381-1389, 2021. e-Pub 2021. PMID: 34398988.
27. Fujii Y, Tzeng CW, Chiang YJ, Halperin DM, Dasari A, Kim MP, Katz MHG, Lee JE, Ikoma N. Incidence of lymph node metastases and impact of radical surgery for duodenal neuroendocrine tumors. J Surg Res 268:419-431, 2021. e-Pub 2021. PMID: 34416414.
28. Wörmann SM, Zhang A, Thege FI, Cowan RW, Rupani DN, Wang R, Manning SL, Gates C, Wu W, Levin-Klein R, Rajapakshe KI, Yu M, Multani AS, Kang Y, Taniguchi CM, Schlacher K, Bellin MD, Katz MHG, Kim MP, Fleming JB, Gallinger S, Maddipati R, Harris RS, Notta F, Ross SR, Maitra A, Rhim AD. APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. Nat Cancer 2(12):1338-1356, 2021. e-Pub 2021. PMID: 35121902.
29. Lamhamedi-Cherradi SE, Mohiuddin S, Mishra DK, Krishnan S, Velasco AR, Vetter AM, Pence K, McCall D, Truong DD, Cuglievan B, Menegaz BA, Utama B, Daw NC, Molina ER, Zielinski RJ, Livingston JA, Gorlick R, Mikos AG, Kim MP, Ludwig JA. Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma. Cancer Gene Ther 28(12):1325-1338, 2021. e-Pub 2021. PMID: 33408328.
30. Huang J, Tian Y, Zhou QJ, Ning JW, Gu ZN, Lu PJ, Li JT, Lin H, Chen TX, Yang YH, Kim MP, Merritt RE, Ghisalberti M, Jiang L, Luo QQ. Comparison of perioperative outcomes of robotic-assisted versus video-assisted thoracoscopic right upper lobectomy in non-small cell lung cancer. Transl Lung Cancer Res 10(12):4549-4557, 2021. PMID: 35070760.
31. Tong YT, Wang H, Wei D, Prakash LR, Kim MP, Tzeng CD, Lee JE, Rashid A, Koay EJ, Wolff RA, Maitra A, Katz MH, Wang H. GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. Pancreatology 21(7):1378-1385, 2021. e-Pub 2021.
32. Del Calvo H, Nguyen DT, Chan EY, Chihara R, Graviss EA, Kim MP. Surgery provides improved overall survival in surgically fit octogenarians with esophageal cancer after chemoradiation therapy. J Thorac Dis 13(10):5875-5886, 2021. PMID: 34795936.
33. Arango NP, Prakash LR, Chiang YJ, Dewhurst WL, Bruno ML, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Risk-stratified pancreatectomy clinical pathway implementation and delayed gastric emptying. J Gastrointest Surg 25(9):2221-2230, 2021. e-Pub 2020. PMID: 33236322.
34. Deng J, Kang Y, Cheng CC, Li X, Dai B, Katz MH, Men T, Kim MP, Koay EA, Huang H, Brekken RA, Fleming JB. Ddr1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. JCI Insight 8;6(17):e146133, 2021. e-Pub 2021. PMID: 34237033.
35. White MG, Lee A, Vicente D, Hall C, Kim MP, Katz MHG, Lee JE, Ikoma N, Lucci A, Tzeng CD. Measurement of portal vein blood circulating tumor cells is safe and may correlate with outcomes in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol 28(8):4615-4622, 2021. e-Pub 2021. PMID: 33415562.
36. Zhao J, Soto LMS, Wang H, Katz MH, Prakash LR, Kim MP, Tzeng CD, Lee JE, Wolff RA, Huang Y, Wistuba II, Maitra A, Wang H. Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. Pancreatology 21(5):942-949, 2021. e-Pub 2021.
37. Kim MP, Li X, Deng J, Zhang Y, Dai B, Allton KL, Hughes TG, Siangco C, Augustine JJ, Kang Y, McDaniel JM, Xiong S, Koay EJ, McAllister F, Bristow CA, Heffernan TP, Maitra A, Liu B, Barton MC, Wasylishen AR, Fleming JB, Lozano G. Oncogenic KRAS recruits an expansive transcriptional network through mutant p53 to drive pancreatic cancer metastasis. Cancer Discov 11(8):2094-2111, 2021. e-Pub 2021. PMID: 33839689.
38. Mohindroo C, Hasanov M, Rogers JE, Dong W, Prakash LR, Baydogan S, Mizrahi JD, Overman MJ, Varadhachary GR, Wolff RA, Javle MM, Fogelman DR, Lotze MT, Kim MP, Katz MHG, Pant S, Tzeng CD, McAllister F. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Med 10(15):5041-5050, 2021. e-Pub 2021. PMID: 34250759.
39. Marchegiani G, Pollini T, Andrianello S, Tomasoni G, Biancotto M, Javed AA, Kinny-Köster B, Amini N, Han Y, Kim H, Kwon W, Kim MP, Perri G, He J, Bassi C, Goh BK, Katz MH, Jang JY, Wolfgang C, Salvia R. Progression vs cyst stability of branch-duct intraductal papillary mucinous neoplasms after observation and surgery. JAMA Surg 1;156(7):654-661, 2021.
40. Dai B, Augustine JJ, Kang Y, Roife D, Li X, Deng J, Tan L, Rusling LA, Weinstein JN, Lorenzi PL, Kim MP, Fleming JB. Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. Cell Death Dis 12(7):693, 2021. e-Pub 2021. PMID: 34247201.
41. Giuliani V, Miller MA, Liu CY, Hartono SR, Class CA, Bristow CA, Suzuki E, Sanz LA, Gao G, Gay JP, Feng N, Rose JL, Tomihara H, Daniele JR, Peoples MD, Bardenhagen JP, Geck Do MK, Chang QE, Vangamudi B, Vellano C, Ying H, Deem AK, Do KA, Genovese G, Marszalek JR, Kovacs JJ, Kim MP, Fleming JB, Guccione E, Viale A, Maitra A, Emilia Di Francesco M, Yap TA, Jones P, Draetta G, Carugo A, Chedin F, Heffernan TP. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Nat Commun 30;12(1):4626, 2021.
42. Nwokedi U, Nguyen DT, Meisenbach LM, Chihara R, Chan EY, Graviss EA, Kim MP. Short-term outcome of routine use of EndoFLIP during hiatal hernia repair. Surg Endosc 35(7):3840-3849, 2021. e-Pub 2020. PMID: 32661713.
43. Ghosh SK, Park J, Na S, Kim MP, Ko H. A fully biodegradable ferroelectric skin sensor from edible porcine skin gelatine. Adv Sci (Weinh) 8(13):2005010, 2021. e-Pub 2021. PMID: 34258158.
44. Gaskill CE, Maxwell J, Ikoma N, Kim MP, Tzeng CW, Lee JE, Katz MHG. History of preoperative therapy for pancreatic cancer and the MD Anderson experience. J Surg Oncol 123(6):1414-1422, 2021. PMID: 33831256.
45. Li X, Xu K, Cen R, Deng J, Hao Z, Liu J, Takizawa H, Ng CSH, Marulli G, Kim MP, Cui F, He J. Preoperative computer tomography-guided indocyanine green injection is associated with successful localization of small pulmonary nodules. Transl Lung Cancer Res 10(5):2229-2236, 2021. PMID: 34164272.
46. Perri G, Prakash L, Wang H, Bhosale P, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay E, Herman J, Kim MP, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Radiographic and serologic predictors of pathologic major response to preoperative therapy for pancreatic cancer. Ann Surg 273(4):806-813, 2021. PMID: 31274655.
47. Jeon MH, Kwon YD, Kim MP, Torres GB, Seo JK, Son J, Ryu YH, Hong SY, Chun JH. Late-Stage 18F/19F isotopic exchange for the synthesis of 18F-labeled sulfamoyl fluorides. Org Lett 23(7):2766-2771, 2021. e-Pub 2021. PMID: 33725454.
48. Chihara RK, Chan EY, Meisenbach LM, Kim MP. Surgical cardiac sympathetic denervation for ventricular arrhythmias: A systematic review. Methodist Debakey Cardiovasc J 17(1):24-35, 2021. e-Pub 2021. PMID: 34104317.
49. Newhook TE, Soliz JM, Prakash LR, Hancher-Hodges S, Speer BB, Wilks JA, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Impact of intraoperative dexamethasone on surgical and oncologic outcomes for patients with resected pancreatic ductal adenocarcinoma. Ann Surg Oncol 28(3):1563-1569, 2021. e-Pub 2020. PMID: 32803553.
50. Clark BS, Swanson M, Widjaja W, Cameron B, Yu V, Ershova K, Wu FM, Vanstrum EB, Ulloa R, Heng A, Nurimba M, Kokot N, Kochhar A, Sinha UK, Kim MP, Dickerson S. ERAS for head and neck tissue transfer reduces opioid usage, peak pain scores, and blood utilization. Laryngoscope 131(3):E792-E799, 2021. e-Pub 2020. PMID: 32516508.
51. Hodges JD, Nguyen DT, Doan J, Meisenbach LM, Chihara R, Chan EY, Graviss EA, Kim MP. Factors associated with home opioid use after thoracic surgery. JTCVS Open 5:173-186, 2021. e-Pub 2020. PMID: 36425360.
52. Kim MP, Um DS, Shin YE, Ko H. High-Performance triboelectric devices via dielectric polarization: A review. Nanoscale Res Lett 16(1):35, 2021. e-Pub 2021. PMID: 33580327.
53. Wei D, Zaid MM, Katz MH, Prakash LR, Kim MP, Tzeng CD, Lee JE, Agrawal A, Rashid A, Wang H, Varadhachary G, Wolff RA, Tamm EP, Bhosale PR, Maitra A, Koay EJ, Wang H. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology 21(1):200-207, 2021. e-Pub 2020.
54. Hakim S, Coronel E, González GMN, Ge PS, Chari ST, Thosani N, Ramireddy S, Badillo R, DaVee T, Catalano MF, Sealock RJ, Parupudi S, Hernandez LV, Joshi V, Irisawa A, Rana S, Lakhtakia S, Vilmann P, Saftoiu A, Sun S, Giovannini M, Katz MH, Kim MP, Bhutani MS. An international study of interobserver variability of "string sign" of pancreatic cysts among experienced endosonographers. Endosc Ultrasound Jan-Feb;10(1):39-50, 2021. PMID: 33473044.
55. Ikoma N, Kim MP, Tzeng CD, Tran Cao HS, Lee JE, Katz MHG. External retraction techniques for robotic pancreatoduodenectomy. J Am Coll Surg 231(5):e8-e10, 2020. e-Pub 2020. PMID: 32805403.
56. Perri G, Prakash L, Malleo G, Caravati A, Varadhachary GR, Fogelman D, Pant S, Koay EJ, Herman J, Maggino L, Milella M, Kim MP, Ikoma N, Tzeng CW, Salvia R, Lee JE, Bassi C, Katz MHG. The sequential radiographic effects of preoperative chemotherapy and (chemo) radiation on tumor anatomy in patients with localized pancreatic cancer. Ann Surg Oncol 27(10):3939-3947, 2020. e-Pub 2020. PMID: 32266574.
57. Bradley SD, Talukder AH, Lai I, Davis R, Alvarez H, Tiriac H, Zhang M, Chiu Y, Melendez B, Jackson KR, Katailiha A, Sonnemann HM, Li F, Kang Y, Qiao N, Pan BF, Lorenzi PL, Hurd M, Mittendorf EA, Peterson CB, Javle M, Bristow C, Kim MP, Tuveson DA, Hawke D, Kopetz S, Wolff RA, Hwu P, Maitra A, Roszik J, Yee C, Lizée G. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers. Nat Commun 21;11(1):5332, 2020.
58. Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim MP, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Response and survival associated with first-line folfirinox vs gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma. JAMA Surg 155(9):832-839, 2020. e-Pub 2020. PMID: 32667641.
59. Wasylishen AR, Sun C, Moyer SM, Qi Y, Chau GP, Aryal NK, McAllister F, Kim MP, Barton MC, Estrella JS, Su X, Lozano G. Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo. Sci Adv 5;6(32):eaba8415, 2020.
60. Manzo T, Prentice BM, Anderson KG, Raman A, Schalck A, Codreanu GS, Nava Lauson CB, Tiberti S, Raimondi A, Jones MA, Reyzer M, Bates BM, Spraggins JM, Patterson NH, McLean JA, Rai K, Tacchetti C, Tucci S, Wargo JA, Rodighiero S, Clise-Dwyer K, Sherrod SD, Kim MP, Navin NE, Caprioli RM, Greenberg PD, Draetta G, Nezi L. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells. J Exp Med 3;217(8):e20191920, 2020. PMID: 32491160.
61. Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. Ann Surg 272(1):163-169, 2020. e-Pub 2018. PMID: 30499795.
62. Wang Z, Hausmann S, Lyu R, Li TM, Lofgren SM, Flores NM, Fuentes ME, Caporicci M, Yang Z, Meiners MJ, Cheek MA, Howard SA, Zhang L, Elias JE, Kim MP, Maitra A, Wang H, Bassik MC, Keogh MC, Sage J, Gozani O, Mazur PK. SETD5-coordinated chromatin reprogramming regulates adaptive resistance to targeted pancreatic cancer therapy. Cancer Cell 37(6):834-849, 2020. e-Pub 2020.
63. Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim MP, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Postoperative chemotherapy benefits patients who received preoperative therapy and pancreatectomy for pancreatic adenocarcinoma. Ann Surg 271(6):996-1002, 2020. PMID: 31895709.
64. Wasylishen AR, Sun C, Chau GP, Qi Y, Su X, Kim MP, Estrella JS, Lozano G. Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress. Proc Natl Acad Sci U S A 117(12):6622-6629, 2020. e-Pub 2020. PMID: 32156729.
65. Prakash LR, Wang H, Zhao J, Nogueras-Gonzalez GM, Cloyd JM, Tzeng CD, Kim MP, Lee JE, Katz MHG. Significance of cancer cells at the vein edge in patients with pancreatic adenocarcinoma following pancreatectomy with vein resection. J Gastrointest Surg 24(2):368-379, 2020. e-Pub 2019. PMID: 30820801.
66. Newhook TE, Vega EA, Vreeland TJ, Prakash L, Dewhurst WL, Bruno ML, Kim MP, Ikoma N, Vauthey JN, Katz MH, Lee JE, Tzeng CD. Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. Surgery 167(2):442-447, 2020. e-Pub 2019. PMID: 31727324.
67. Cazacu IM, Luzuriaga Chavez AA, Mendoza TR, Qiao W, Singh BS, Bokhari RH, Saftoiu A, Lee JH, Weston B, Stroehlein JR, Kim MP, G Katz MH, Maitra A, McAllister F, Bhutani MS. Quality of life impact of EUS in patients at risk for developing pancreatic cancer. Endosc Ultrasound Jan-Feb;9(1):53-58, 2020.
68. Vicente D, Lee AJ, Hall CS, Lucci A, Lee JE, Kim MP, Katz MHG, Hurd MW, Maitra A, Rhim Md AD, Tzeng CD. Circulating tumor cells and transforming growth factor beta in resected pancreatic adenocarcinoma. J Surg Res 243:90-99, 2019. e-Pub 2019. PMID: 31170555.
69. Mottini C, Tomihara H, Carrella D, Lamolinara A, Iezzi M, Huang JK, Amoreo CA, Buglioni S, Manni I, Robinson FS, Minelli R, Kang Y, Fleming JB, Kim MP, Bristow CA, Trisciuoglio D, Iuliano A, Del Bufalo D, Di Bernardo D, Melisi D, Draetta GF, Ciliberto G, Carugo A, Cardone L. Predictive signatures inform the effective repurposing of decitabine to treat KRAS-dependent pancreatic ductal adenocarcinoma. Cancer Res 79(21):5612-5625, 2019. e-Pub 2019. PMID: 31492820.
70. Kazi A, Xiang S, Yang H, Chen L, Kennedy P, Ayaz M, Fletcher S, Cummings C, Lawrence HR, Beato F, Kang Y, Kim MP, Delitto A, Underwood PW, Fleming JB, Trevino JG, Hamilton AD, Sebti SM. Dual farnesyl and geranylgeranyl transferase inhibitor thwarts mutant KRAS-driven patient-derived pancreatic tumors. Clin Cancer Res 25(19):5984-5996, 2019.
71. Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB, Hancher-Hodges S, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Inpatient opioid use after pancreatectomy: Opportunities for reducing initial opioid exposure in cancer surgery patients. Ann Surg Oncol 26(11):3428-3435, 2019. e-Pub 2019. PMID: 31243665.
72. Lee AJ, Simoneau E, Chiang YJ, Lee JE, Kim MP, Aloia TA, Vauthey JN, Katz MH, Tzeng CD. Is early-stage pancreatic adenocarcinoma truly early: Stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. HPB (Oxford) 21(9):1203-1210, 2019. e-Pub 2019. PMID: 30799277.
73. Florez Bedoya CA, Cardoso ACF, Parker N, Ngo-Huang A, Petzel MQ, Kim MP, Fogelman D, Romero SG, Wang H, Park M, Katz MHG, Schadler KL. Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients. Sci Rep 9(1):13966, 2019.
74. Kim MP, Swisher SG. Heterogeneity of stage IIIA leads to difficulty in determining optimal treatment. J Thorac Dis (Suppl 15):S2043-S2045, 2019.
75. Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do KA, Peterson CB, Nejman D, Tzeng CD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister F. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178(4):795-806.e12, 2019.
76. Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG. The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg 218(1):145-150, 2019. e-Pub 2018. PMID: 30224070.
77. Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD. Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization. HPB (Oxford) 21(7):841-848, 2019. e-Pub 2018. PMID: 30501986.
78. Vreeland TJ, McAllister F, Javadi S, Prakash LR, Fogelman DR, Ho L, Varadhachary G, Aloia TA, Vauthey JN, Lee JE, Kim MP, Katz MHG, Tzeng CD. Benefit of gemcitabine/nab-paclitaxel rescue of patients with borderline resectable or locally advanced pancreatic adenocarcinoma after early failure of folfirinox. Pancreas 48(6):837-843, 2019.
79. Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD. Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. HPB (Oxford) 21(6):662-668, 2019. e-Pub 2018. PMID: 30522947.
80. Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HA. Single cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression. Clin Cancer Res 25(7):2194-2205, 2019. e-Pub 2018. PMID: 30385653.
81. Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG. Chemotherapy versus chemoradiation as preoperatie therapy for resectable pancreatic ductal adenocarcinoma: A propensity score adjusted analysis. Pancreas 48(2):48(2):216-222, 2019. PMID: 30629022.
82. Seth S, Li CY, Ho IL, Corti D, Loponte S, Sapio L, Del Poggetto E, Yen EY, Robinson FS, Peoples M, Karpinets T, Deem AK, Kumar T, Song X, Jiang S, Kang Y, Fleming J, Kim MP, Zhang J, Maitra A, Heffernan TP, Giuliani V, Genovese G, Futreal A, Draetta GF, Carugo A, Viale A.. Pre-existing functional heterogeneity of tumorigenic compartment as the origin of chemoresistance in pancreatic tumors. Cel Rep 26(6):1518-1532, 2019. e-Pub 2019. PMID: 30726735.
83. Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD. Pancreaticoduodenectomy with mesocaval shunt for locally advanced pancreatic adenocarcinoma. Ann Surg Oncol 26(2):652, 2019. e-Pub 2018. PMID: 30539487.
84. Liu S, Hausmann S, Carlson SM, Fuentes ME, Francis JW, Pillai R, Lofgren SM, Hulea L, Tandoc K, Lu J, Li A, Nguyen ND, Caporicci M, Kim MP, Maitra A, Wang H, Wistuba II, Porco JA, Bassik MC, Elias JE, Song J, Topisirovic I, Van Rechem C, Mazur PK, Gozani O. METTL13 methylation of eEF1A increases translational output to promote tumorigenesis. Cell 176(3):491-504, 2019. e-Pub 2019. PMID: 30612740.
85. Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, Lucas FAS, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JB. A visually apparent and quantifiable CT imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma. Clin Cancer Res 24(23):5883-5894, 2018. e-Pub 2018. PMID: 30082477.
86. Li X, Lee Y, Kang Y, Dai B, Perez MR, Pratt M, Koay EJ, Kim MP, Brekken RA, Fleming JB. Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma. Cell Death and Differ 2(26):382-393, 2018. e-Pub 2018.
87. Denbo JW, Bruno M, Dewhurst W, Kim MP, Tzeng CW, Aloia TA, Soliz J, Speer BB, Lee JE, Katz MHG. Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery 164(3):424-431, 2018. e-Pub 2018. PMID: 29807648.
88. Katz MH, Kim MP, Tzeng CW, Lee JE. Preoperative chemoradiation for borderline resectable pancreatic cancer: The new standard?. Ann Surg 268(2):223-224, 2018.
89. Ivanics T, Bergquist JR, Liu G, Kim MP, Kang Y, Katz MH, Perez MVR, Thomas RM, Fleming JB, Truty MJ. Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant type. Lab Invest 98(7):947-956, 2018. e-Pub 2018.
90. Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD. Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis. J Surg Oncol 117(8):1648-1654, 2018. e-Pub 2018. PMID: 29723419.
91. Goumard C, Ogiso S, Okuno M, Fleming JB, Kim MP, Tzeng CDW, Vauthey JN, Lee JE, Conrad C. Tips and tricks of splenic vessel preservation during laparoscopic distal pancreatectomy. Surg Endosc 32(4):2149-2150, 2018. e-Pub 2017. PMID: 28733741.
92. Cloyd JM, Nogueras-Gonzalez G, Prakash L, Petzel MQB, Parker NH, Ngo-Huang AT, Fogelman D, Denbo JW, Garg N, Kim MP, Lee JE, Tzeng CWD, Fleming JB, Katz MHG. Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy. J Gastrointest Surg 22(4):703-712, 2018. e-Pub 2017.
93. Wang YN, Lee HH, Chou CK, Yang WH, Wei Y, Chen CT, Yao J, Hsu JL, Zhu C, Ying H, Ye Y, Wang WJ, Lim SO, Xia W, Ko HW, Liu X, Liu CG, Wu X, Wang H, Li D, Prakash LR, Katz MH, Kang Y, Kim MP, Fleming JB, Fogelman D, Javle M, Maitra A, Hung MC. Angiogenin/ribonuclease 5 is an EGFR ligand and a serum biomarker for erlotinib sensitivity in pancreatic cancer. Cancer Cell 33(4):752-769, 2018. e-Pub 2018.
94. Fonseca AL, Kirkwood K, Kim MP, Maitra A, Koay EJ. Intraductal papillary mucinous neoplasms of the pancreas: Current understanding and future directions for stratification of malignancy risk. Pancreas 47(3):272-279, 2018.
95. Kim MP, Lozano G. Mutant p53 partners in crime. Cell Death Differ 25(1):161-168, 2018. e-Pub 2017.
96. Yamashita S, Overman MJ, Wang H, Zhao J, Okuno M, Goumard C, Tzeng CWD, Kim MP, Fleming JB, Vauthey JN, Katz MHG, Lee JE, Conrad C. Pathologic response to preoperative therapy as a novel prognosticator for ampullary and duodenal adenocarcinoma. Ann Surg Oncol 24(13):3954-3963, 2017. e-Pub 2017.
97. Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHG. Association of clinical factors with a major pathologic response following preoperative therapy for pancreatic ductal adenocarcinoma. JAMA Surg 152(11):1048-1056, 2017. e-Pub 2017.
98. Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim MP, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman R. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357(6356):1156-1160, 2017. PMID: 28912244.
99. Cloyd JM, Wang H, Overman M, Zhao J, Denbo J, Prakash L, Kim MP, Shroff R, Javle M, Varadhachary GR, Fogelman D, Wolff RA, Koay EJ, Das P, Maitra A, Aloia TA, Vauthey JN, Fleming JB, Lee JE, Katz MHG. Influence of preoperative therapy on short- and long-term outcomes of patients with adenocarcinoma of the ampulla of vater. Ann Surg Oncol 24(7):2031-2039, 2017. e-Pub 2017. PMID: 28124275.
100. Vega EA, Yamashita S, Chun YS, Kim MP, Fleming JB, Katz MH, Tzeng CW, Raghav KP, Vauthey JN, Lee JE, Conrad C. Effective laparoscopic management lymph node dissection for gallbladder cancer. Ann Surg Oncol 24(7):1852, 2017. e-Pub 2017. PMID: 28168387.
101. Denbo JW, Slack RS, Bruno M, Cloyd JM, Prakash L, Fleming JB, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG. Selective perioperative administration of pasireotide is more cost-effective than routine administration for pancreatic fistula prophylaxis. J Gastrointest Surg 21(4):636-646, 2017. e-Pub 2017. PMID: 28050766.
102. Vega EA, Yamashita S, Shin CY, Kim MP, Fleming JB, Katz MH, Raghav KP, Vauthey JN, Lee JE, Conrad C. Laparoscopic partial splenectomy for unknown primary cancer: A stepwise approach. Ann Surg Oncol 24(4):1134, 2017. e-Pub 2016. PMID: 27942901.
103. Cloyd JM, Tran Cao HS, Petzel MQ, Denbo J, Parker NH, Liles JS, Kim MP, Lee JE, Vauthey JN, Fleming JB, Katz MHG. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Onc 115(2):144-150, 2017. e-Pub 2016. PMID: 27859270.
104. Prakash L, Bhosale, Priya B, Jordan MC, Kim MP, Parker N, Yao J, Dasari A, Halperin DM, Verma A, Aloia T, Lee JE, Vauthey JN, Fleming JB, Katz MHG. Role of fluorouracil, doxorubicin and streptozocin therapy in the preoperative treatment of localized pancreatic neuroendocrine tumors. J Gastrointest Surg 21(1):1554-163, 2017. e-Pub 2016. PMID: 27634306.
105. Cloyd JM, Katz MHG, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky B, Lee JH, Bhutani M, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PWT, Evans DB, Lee JE. Preoperative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A 25 year single-institution experience. J Gastrointest Surg 21(1):164-174, 2017. e-Pub 2016. PMID: 27778257.
106. Denbo J, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim MP, Crane CH, Koay EJ, Krishnan S, Das P, Minsky BD, Vardhachary G, Shroff R, Wolf RA, Javle M, Overman MJ, Fogelman DF, Aloia TA, Vauthey JN, Fleming JB, Katz MHG. Preoperative chemoradiation for pancreatic adenocarcinoma does not increase 90-day postoperative morbidity or mortality. J Gastrointest Surg 20(12):1975-1985, 2016. e-Pub 2016. PMID: 27730398.
107. Conrad C, Kutlu OC, Dasari A, Chan JA, Vauthey JN, Adams DB, Kim MP, Fleming JB, Katz MHG, Lee JE. Prognostic value of lymph node status and extent of lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointes Surg 20(12):1966-1974, 2016. e-Pub 2016. PMID: 27714644.
108. Conrad C, Passot G, Katz MHG, Fleming JB, Kim MP, Chun YS, Aloia TA, Vauthey JN, Lee JE. Laparoscopic insulinoma enucleation from the retro-pancreatic neck: A stepwise approach. Ann Surg Oncol 23(6):2001, 2016. e-Pub 2016. PMID: 26960928.
109. Thomas RM, Truty MJ, Kim MP, Kang Y, Zhang R, Chatterjee D, Katz MHG, Fleming JB. The canary in the coal mine: The growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma. Ann Surg Oncol 22(6):1884-1892, 2015.
110. Kim MP, Truty MJ, Choi W, Kang Y, Chopin-Lally X, Gallick GE, Wang H, McConkey DJ, Hwang R, Logsdon C, Abbruzzesse JL, Fleming JB. Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy. Ann Surg Oncol 19 Suppl 3(0 3):S395-403, 2012. e-Pub 2011. PMID: 21701930.
111. Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS One 6(6):e20636, 2011.
112. Kopetz S, Lesslie DP, Dallas NA, Park SI, Johnson M, Parikh NU, Kim MP, Abbruzzese JL, Ellis LM, Chandra J, Gallick GE. Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress. Cancer Res 69(9):3842-3849, 2009. PMID: 19383922.
113. Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G 2nd, Samuel S, Kim MP, Lim SJ, Ellis LM.. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 69(5):1951-1957, 2009. PMID: 19244128.
114. Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc 4(11):1670-1680, 2009. e-Pub 2009. PMID: 19876027.
115. Wang HQ, Kim MP, Tiano HF, Langenbach R, Smart RC. Protein kinase C-α coordinately regulates cytosolic phospholipase A2 activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes. Mol Pharmacology 59(4):860-866, 2001. PMID: 11259631.

Invited Articles

1. Kim MP, Lozano G. Mutant p53 partners in crime. Cell Death Differentiation 25(1):161-168, 2018. e-Pub 2017.
2. Kim MP, Zhang Y, Lozano G.. Mutant p53: Multiple mechanisms define biologic activity in cancer. Front Oncol 5(249), 2015.
3. Kim MP, Evans DB, Vu TM, Fleming JB. The recognition and surgical management of heritable lesions of the pancreas. Surg Oncol Clin N Am 18(1):99-119, 2009. PMID: 19056044.

Other Articles

1. Kim MP, Schroeppel TJ, Fabian TC Nonoperative management of traumatic rupture of splenosis. Injury Extra 39:147-149, 2008.

Editorials

1. Kim MP, Katz MHG. Perioperative therapy for borderline resectable pancreatic cancer: what and when?. Ann Surg Oncol 26(6):1596-1597, 2019. PMID: 30680479.
2. Kim MP, Gallick GE. Gemcitabine resistance in pancreatic cancer: Picking the key players. Clinical Cancer Research 14(5):1284-1285, 2008. PMID: 18316544.

Abstracts

1. Schalck A, Sakellariou-Thompson D, Forget MA, Sei E, Hughes, T, Bai S, Hu M, Kumar T, Hurd M, Katz M, Tzeng CW, Pant S, Javle M, Maitra A, Haymaker C, Kim MP, Navin N, Bernatchez C. Simultaneous TCR and transcriptomic sequencing of single Tcells defines biological subtypes in pancreatic cancer for adoptive Tcell therapy. AACR Annual Meeting 2022 82(12 Supplement), 2022.
2. Zhao M, Prakash LR, Hill V, Chiang YJ, Lee J, Ross WA, Coronel E, Ge PS, Weston BR, Maxwell JE, Newhook TE, Tzeng CW, Ikoma N, Lee JE, Katz M, Bhutani MS, Kim MP. Cyst fluid glucose levels are superior to cyst fluid cea levels in the identification of mucinous pancreatic cysts. Society for Surgery of the Alimentary Tract, 2022.
3. Zhao M, Prakash LR, Hill V, Maxwell JE, Newhook TE, Ikoma N, Tzeng CW, Lee JE, Katz M, Kim MP. Development of an accumulation index to identify pancreatic side branch intraductal papillary mucinous neoplasms with underlying malignancy. Society for Surgery of the Alimentary Tract, 2022.
4. Concors S, Arvide EM, Prakash LR, Soones T, Ngo-Huang A, Nguyes VQ, Newhook TE, Ikoma N, Maxwell JE, Cao HT, Chun YS, Kim MP, Lee JE, Vauthey JN, Katz M, Tzeng, CW. Mitigating morbidity in older patients undergoing major pancreatic and hepatobiliary surgery. Society for Surgery of the Alimentary Tract, 2022.
5. Thunshelle C, Chowdhury T, Zaid M, Jaoude JA, Dai A, Kirimli E, Prakash L, Katz M, Tzeng CW, Kim MP, Wolff R, Pant S, Smaglo B, Ludmir E, Holliday E, Das P, Minsky B, Taniguchi C, Koong A, Koay E. Effect of radiotherapy (RT) on outcomes in patients (pts) with borderline resectable and locally advanced pancreatic ductal adenocarcinoma (BRPC, LAPC). Annual Meeting Scientific Program Committee of the American Society for Radiation Oncology (ASTRO) 63rd Annual Meeting 111(3), 2021.
6. Witt R, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CWD. Impact of first-day intravenous patient controlled analgesia use on total inpatient opioid use after pancreatectomy. SAAS, 2021.
7. Srinivasan S, Rose J, Yao W, Seth S, Peoples M, Machado A, Li CY, Ho IL, Lee JJ, Guerrera PA, Kim E, Syed M, Daniele J, Deem AK, Kim MP, Bristow CA, Koay E, Genovese G, Viale A, Heffernan TP, Maitra A, Hart T, Carugo A, Draetta G. Diversity across the pancreatic ductal adenocarcinoma disease spectrum revealed by network-anchored functional genomics. AACR Annual Meeting 2021, 2021.
8. Donovan EC, Dai B, Deng J, Siangco CM, Li X, Faraoni EY, Evans SM, Kim MP. Wnt11 dictates the patterns and latency of pulmonary micrometastatic disease in pancreatic cancer. AACR Annual Meeting 2021, 2021.
9. Kim MP, Li X, Deng, Zhang Y, Dai B, Allton K, Hughes T, Siangco C, Augustine J, Kang Y, McDaniel JM, Xiong S, Koay E, McAllister F, Bristow C, Heffernan T, Maitra A, Liu B, Barton M, Wasylischen A, Fleming J, Lozano G. Mutant p53 and oncogenic KRAS converge on CREB1 to drive pancreatic cancer metastasis. AACR Annual Meeting 2021, 2021.
10. Newhook TE, Kim MP, Chiang YJ, Tzeng CW, Ikoma N, Vauthey JN, Aloia T, Lee JE, Katz M, Tran Cao H. 1052 Oncologic outcomes of cyst-associated vs. classical pancreatic ductal adenocarcinoma. Gastroenterology:S-1549, 2020.
11. Lashof-Sullivan M, McSweeney AL, Ting DT, Kim MP, Tzeng CW, Indolfi L. Targeted and sustained drug delivery therapy for localized pancreatic cancer: In vivo validation in porcine models. AACR Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care, 2019.
12. Hughes T, Li X, Dai B, Deng J, Siangco C, Das K, Bai S, Hu M, Sei E, Seth T, Navin N, Kim MP. Wnt11 drives PDAC cell migration and invasion and is associated with β-integrin signaling pathways. Pancreas Club, 2019.
13. Dai B, Freed DM, Sorrentino JA, Augustine JJ, Hughes TG, Kang Y, Roberts PJ, Fleming JB, Kim MP. CDK4/6 inhibition with lerociclib (G1T38) enhances response to PI3K or ERK inhibitors in high-throughput, ex vivo pancreatic PDX screens. AACR Annual Meeting 2019, 2019.
14. Hasanov M, Mohindroo C, Rogers J, Prakash L, Overman M, Varadhachary G, Wolff R, Javle M, Fogelman D, Pant S, Katz M, Kim MP, Tzeng CW, McAllister F. The effect of antibiotic use on survival of patients with resected pancreatic ductal adenocarcinoma. ASCO Annual 2019 37(suppl; abstract e15773), 2019.
15. Montiel M, Quesada P, Dunseith M, Cazacu I, Luzuriaga A, Dong W, Bannon S, Mork M, Feng L, You YN, Sanchez E, Arun B, Brown P, Kim MP, Katz M, Maitra A, Bhutani M, McAllister F. New onset diabetes as a predictive factor of focal lesions in the pancreas in a high-risk screening program. ASCO Annual 2019 37(suppl; abstract 1512), 2019.
16. Hughes T, Li X, Dai B, Siangco C, Das K, Bai S, Min H, Kumar T, Sei E, Navin N, Kim MP. Wnt11 promotes pancreatic cancer cell motility and invasion. Society for Surgery of the Alimentary Tract Annual Meeting, 2019.
17. Hughes T, Prakash LR, Maitra A, Bhutani MS, McAllister F, Ross WA, Weston BR, Koay E, Wang H, Lee J, Vauthey JN, Lee JE, Aloia T, Tzeng CW, Katz M, Kim MP. Pancreatic duct caliber does not reliably distinguish malignant from premalignant main duct IPMNs. Society for Surgery of the Alimentary Tract Annual Meeting, 2019.
18. Hughes TG, Prakash LR, Lee JE, Wang H, Katz MHG, Tzeng CD, Vauthey JN, Aloia TA, Lee JH, Koay EJ, Ross WA, Weston BR, Maitra A, McAllister F, Fleming JB, Kim MP. Pancreatic duct caliber should not be used as the sole justification for surgical selection in main duct IPMNs. Pancreas Club, 2019.
19. Hughes T, Li X, Dai B, Deng J, Siangco C, Das K, Bai S, Hu M, Sei E, Seth T, Navin N, Kim MP. Wnt11 regulates migration and invasion in pancreatic ductal adenocarcinoma. AACR 2019, 2019.
20. Hughes T, Prakash LR, Lee J, Bhutani M, Weston B, Ross W, Wang H, Koay E, Maitra A, McAllister F, Lee JE, Aloia T, Vauthey J, Tzeng CD, Katz MGH, Kim MP. Predictive value of preoperative fine needle aspiration biopsy in the identification of IPMN-associated adenocarcinoma. Society of Surgical Oncology 72nd Annual Cancer Symposium, 2019.
21. James L, Prakash LR, Vauthey JN, Aloia TA, Tzeng CWD, Fleming JB, Lee JE, Katz MHG, Kim MP. The impact of tumor differentiation on perioperative outcomes and patterns of recurrence following preoperative therapy for resectable pancreatic adenocarcinoma. 13th IHPBA World Congress,, 2018.
22. Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Conrad C, Kim MP, Katz MHG, Tzeng CWD. Improved superior mesenteric artery exposure and reduced blood loss risk using temporary mesocaval shunt for locally advanced pancreatic cancer. 13th IHPBA World Congress, 2018.
23. Newhook T, Dewhurst W, Chen HC, Wang X, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CWD. Variation in and predictors of inpatient opioid utilization after pancreatectomy. 13th IHPBA World Congress, 2018.
24. Dewhurst W, Newhook T, Chen HC, Wang X, Bruno M, Kim MP, Vauthey JN, Lee JE, Katz MHG, Tzeng CWD. Impact of first-day intravenous patient controlled analgesia use on total inpatient opioid use after pancreatectomy. 13th IHPBA World Congress, 2018.
25. Lee A, Simoneau EB, Chiang YJ, Lee J, Kim MP, Aloia T, Vauthey JN, Katz M, Tzeng CW. Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first vs. neoadjuvant therapy sequencing. 13th IHPBA World Congress, 2018.
26. Hughes TG, LI X, Das K, Dai B, Kim MP. WNT11 confers chemoresistance and promotes tumor cell survival in pancreatic adenocarcinoma. Pancreas Club, 2018.
27. Snyder RA, Prakash LR, Narula N, Kim BJ, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CWD. Impact of perioperative blood transfusions of survival in patients with borderline resectable pancreatic adenocarcinoma after neoadjuvant therapy. Americas Hepato-Pancreato-Biliary Association Annual Meeting, 2018.
28. Conrad C, Tzeng CWD, Lee JE, Aloia TA, Chun YS, Katz MHG, Kim MP, Vauthey JN, Simoneau E, Goumard C. Pancreaticoduodenectomy with mesocaval shunt for locally advanced pancreatic adenocarcinoma. Americas Hepato-Pancreato-Biliary Association, 2018.
29. Hughes TH, Siangco CR, Das K, Kang Y, Kim MP. WNT-11 reduces migration and invasion in pancreatic ductal adenocarcinoma. Society of Surgical Oncology (SSO) 2018 Meeting, 2018.
30. Lee A, Chiang YJ, Kim MP, Conrad C, Aloia TA, Vauthey JN, Katz MHG, Lee JE, Tzeng CWD. Validation of AJCC 8 staging system and prognostic value of lymph node ratio for resectable pancreatic adenocarcinoma after neoadjuvant therapy. The Society of Surgical Oncology (SSO) Annual Cancer Symposia, 2018.
31. Hughes T, Siangco CR, Das K, Kang Y, Kim MP. WNT-11 negatively regulates cancer cell migration and invasion. Society of Surgical Oncology Annual, 2018.
32. Kim BJ, Vreeland T, Davis CH, Narula N, Kim MP, Katz MHG, Lee JE, Tzeng CWD, Chun YS, Conrad C, Vauthey JN, Aloia TA. Multi-institutional analysis of frequency, risk factors and outcomes for 537 simultaneous pancreatectomy/hepatectomy procedures. Langenbeck’s Archives of Surgery 19:S48, 2017. e-Pub 2017.
33. Kim MP. Mutant p53 exerts pro-metastatic functions while altering the tumor microenvironment in pancreatic adenocarcinoma. Pancreas Club Meeting, 2017.
34. Snyder RA, Prakash LR, Narula N, Kim BJ, Noguertas, GG, Katz MHG, Fleming JB, Lee JE, Aloia TA, Vauthey JN, Kim MP, Tzeng CWD. Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis. Pancreas Club meeting, 2017.
35. Snyder RA, Prakash LR, Narula N, Kim BJ, Noguertas, GG, Katz MHG, Fleming JB, Lee JE, Aloia TA, Vauthey JN, Kim MP, Tzeng CWD. Progressive decline in perioperative blood transfusions for vascular resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization. Pancreas Club Meeting, 2017.
36. Denbo JW, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim MP, Crane CH, Koay EJ, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Preoperative chemoradiation for pancreatic adenocarcinoma does not increase 90-day postoperative morbidity or mortality. Society for Surgery of the Alimentary Tract Annual Meeting, 2016.
37. Cloyd JM, Crane CH, Koay EJ, Snyder RS, Das P, Krishnan S, Wang H, Kim MP, Lee JE, Varadhachary G, Javle M, Shroff R, Wolff R, Fogelman D, Katz MH. Preoperative therapy for patients with pancreatic ductal adenocarcinoma undergoing pancreatoduodenectomy: Impact of radiation dose on outcomes. Society for Surgery of the Alimentary Tract Annual Meeting, 2016.
38. Denbo JW, Slack RS, Bruno ML, Fleming JB, Kim MP, Lee JE, Katz MH. Selective administration of prophylactic pasireotide is cost effective. Society for Surgery of the Alimentary Tract Annual Meeting, 2016.
39. Conrad C, Passot G, Katz MH, Fleming JB, Kim MP, Chun YS, Aloia TA, Vauthey JN, Lee JE. Laparoscopic insulinoma enucleation from the retro-pancreatic neck: A stepwise approach. IHPBA World Congress Conference, 2016.
40. Kim MP, Tran Cao HS, Katz MH, Pisters PW, Curley SA, Vauthey JN, Aloia TA, Evans DB, Lee JE, Fleming JB. Central pancreatectomy and distal pancreatectomy for pancreatic neck lesions result in equivalent long term pancreatic function and fistula formation. Annual Meeting of the Society of Surgical Oncology, 2014.
41. Kim MP, Evans DB, Wang H, Gallick GE, Fleming JB. Prevalence of putative cancer stem cell markers in pancreatic tumor systems. American Association for Cancer Research Annual Meeting, 2009.
42. Kim MP, Evans DB, Wang H, Gallick GE, Fleming JB. Establishment of human pancreatic cancer tumor xenografts after preoperative therapy and pancreatectomy. Annual Meeting of the Society of Surgical Oncology, 2009.
43. Kim MP, Fleming JB, Evans DB, Wang HM, Gallick GE. Pancreatic cancer xenografts contain distinct populations of cells expressing the cancer stem cell marker CD133. American Society of Clinical Oncology- Gastrointestinal Cancers Symposium, 2009.
44. Kim MP, Gallick GE, Evans, DB, Wang HM, Fleming JB. Preoperative therapy limits but does not prevent engraftment of pancreatic adenocarcinoma tumor in mice after pancreatectomy. American Society of Clinical Oncology- Gastrointestinal Cancers Symposium, 2009.
45. Kim MP, Blazer DG, Abdalla EK, Pisters PW, Lee JE, Evans DB, Fleming JB. Central pancreatectomy preserves pancreatic endocrine function. Annual Pancreas Club Meeting, 2008.
46. Kim MP, Shah AN, Zhang J, Parikh N, Abbruzzese JL, Gallick GE. Gemcitabine resistance in cultured pancreatic tumor cells is associated with down regulation of PTEN and a mesenchymal phenotype. Annual American Association of Cancer Research Meeting, 2008.
47. Kim MP, Shah AN, Gallick GE. Gemcitabine resistance in cultured pancreatic tumor cells is associated with downregulation of PTEN and activation of FAK. Society of Surgical Oncology Annual Meeting, 2008.
48. Kim MP, Shah AN, Parikh NU, Gallick GE. Gemcitabine resistance in pancreatic cancer cells is associated with increased expression of stem cell-like markers and a concomitant down-regulation of PTEN and activation of AKT. American Pancreatic Association Annual Meeting, 2007.

Book Chapters

1. Pudakalakatti S, Raj P, Salzillo TC, Enriquez JS, Bourgeois D, Dutta P, Titus M, Shams S, Bhosale P, Kim MP, McAllister F, Bhattacharya PK. Metabolic imaging using hyperpolarization for assessment of premalignancy. In: Methods Mol Biol, 169-180, 2022.
2. Kim MP and Badgwell BD. Pancreatic neuroendocrine tumors. In: Fischer’s Mastery of Surgery 7th Edition. Vol. 1 (45). Wolters Kluwer, 583-592, 2017.
3. eCollection. Haupt Y, Blandino G. Editorial: Human tumor-derived p53 mutants: A growing family of oncoproteins. In: Front Oncol. Wolters Kluwer Health for Mastery of Surgery, 2016.
4. Bhutani M, Wolff R, Kwan A, Rodgers H, Kim MP. In: Pancreatic Cancer: A Multidisciplinary Approach.